Navigation Links
HALO Infant Protection System

ProductsHALO Infant Protection System
Company VeriChip Corporation
Item HALO Infant Protection System
Features 
  • Unique-skin sensing RFID tags
  • Software provides visual indication of the location
  • System records all activity (e.g. alarms, bypass) for automated record keeping
  • Staff Tag also provides hands-free access through
Description The HALO Infant Protection System helps protect infants, patients, staff, and vital medical equipment to ensure the operating efficiencies, cost savings, and overall peace of mind possible even in todays busy and constrained healthcare facilities.

And with HALO, youre not only getting the most reliable and versatile solution, but also unique-skin sensing RFID tags that provide ample notification once removed from an infant even if the infant loses weight. HALO is more than just infant protection, resulting in a greater return on investment for your facility.

Info VeriChip Corporation
Customer Service: (800) 970-CHIP
Web site: http://www.verichipcorp.com/index.html

Related medicine products :

1. Cook Eye Speculum - Infant
2. Sauer Eye Speculum - Infant
3. Saunders Eye Speculum - Premature Infant
4. Desmarres Infant Retractor
5. Infant Lacrimal Dilator
6. Infant Bika
7. Endotracheal Tube Stylet - Infant
8. Trachlight Wand Reusable Infant
9. Neo / Infant Perfect Fit Tracheostomy Collar™
10. Dale® Tracheostomy Tube Holder - Neonatal to Infant
11. Infant Portex Velcro® Tracheostomy Tube Holder
Breaking Medicine Technology:Federal Judge Rejects GlaxoSmithKline's Claims of Privilege 2AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 2AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 3Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3Policy transparency key to saving worlds fisheries 8955 1Policy transparency key to saving worlds fisheries 8955 2Policy transparency key to saving worlds fisheries 8955 3Policy transparency key to saving worlds fisheries 8955 4Policy transparency key to saving worlds fisheries 8955 5Domestic Violence Expert Comments on Chris Brown Plea Deal 49697 1Domestic Violence Expert Comments on Chris Brown Plea Deal 49697 2Cytel Signs Cooperative Research And Development Agreement With FDA Center for Devices and Radiological Health 28CDRH 29 4629 1Cytel Signs Cooperative Research And Development Agreement With FDA Center for Devices and Radiological Health 28CDRH 29 4629 2Cytel Signs Cooperative Research And Development Agreement With FDA Center for Devices and Radiological Health 28CDRH 29 4629 3